Out of the 20 BRCA1/2 positive patients, 17 were diagnosed with ovarian serous adenocarcinoma (85 %), whereas the other three with adenocarcinoma endometroides (15 %). Here, BRCA1 is linked to ovarian serous adenocarcinoma.